Shaimol, T. published the artcileWilson disease-an overview, COA of Formula: C6H20Cl2N4, the publication is World Journal of Pharmaceutical Research (2017), 6(1), 154-175, database is CAplus.
A review. Wilson disease is a rare inherited disorder that prevents the body from getting rid of extra copper. Our body needs a small amount of copper from food to stay healthy. Too much copper is poisonous. The condition is due to mutations in the Wilson disease protein (ATP7B) gene. Normally liver releases extra copper into bile. With Wilson disease, the copper builds up in liver and it releases the copper directly into bloodstream. This can cause damage to brain, kidneys and eyes. Wilson disease is present at birth, but symptoms usually start between ages 5 and 35. It first attacks the liver, the central nervous system or both. The most characteristic sign is a rusty brown ring around the cornea of the eye. A phys. exam and laboratory tests can diagnose it. Treatment is with drugs to remove the extra copper from body. It needs to take medicine and follow a low-copper diet for the rest of life. WD is treated with medication that reduces copper absorption or removes the excess copper from the body, but occasionally a liver transplant is required. A single abnormal copy of the gene is present in 1 in 100 people, who do not develop any symptoms (they are carriers). If a child inherits the gene from both parents, the child may develop Wilson’s disease. Wilson’s disease occurs in 1 to 4 per 100,000 people.
World Journal of Pharmaceutical Research published new progress about 38260-01-4. 38260-01-4 belongs to catalysis-chemistry, auxiliary class Chelating Agents, name is N1,N1′-(Ethane-1,2-diyl)bis(ethane-1,2-diamine) dihydrochloride, and the molecular formula is C7H8BNO5, COA of Formula: C6H20Cl2N4.
Referemce:
https://courses.lumenlearning.com/boundless-chemistry/chapter/catalysis/,
Catalysis – Wikipedia